Description: Homo sapiens Fanconi anemia, complementation group A (FANCA), transcript variant 1, mRNA. RefSeq Summary (NM_000135): The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]. Transcript (Including UTRs) Position: hg19 chr16:89,803,959-89,883,065 Size: 79,107 Total Exon Count: 43 Strand: - Coding Region Position: hg19 chr16:89,805,009-89,883,023 Size: 78,015 Coding Exon Count: 43
ID:FANCA_HUMAN DESCRIPTION: RecName: Full=Fanconi anemia group A protein; Short=Protein FACA; FUNCTION: DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be involved in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability. SUBUNIT: Belongs to the multisubunit FA complex composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM. The complex is not found in FA patients. In complex with FANCF, FANCG and FANCL, but not with FANCC, nor FANCE, interacts with HES1; this interaction may be essential for the stability and nuclear localization of FA core complex proteins. The complex with FANCC and FANCG may also include EIF2AK2 and HSP70. Interacts with FAAP20/C1orf86; interaction is direct. INTERACTION: Q9NPI8:FANCF; NbExp=5; IntAct=EBI-81570, EBI-81589; O15287:FANCG; NbExp=6; IntAct=EBI-81570, EBI-81610; P62993:GRB2; NbExp=2; IntAct=EBI-81570, EBI-401755; SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=The major form is nuclear. The minor form is cytoplasmic. PTM: Phosphorylated upon DNA damage, probably by ATM or ATR. Phosphorylation is required for the formation of the nuclear complex. Not phosphorylated in cells derived from groups A, B, C, E, F, G, and H. DISEASE: Defects in FANCA are a cause of Fanconi anemia (FA) [MIM:227650]. FA is a genetically heterogeneous, autosomal recessive disorder characterized by progressive pancytopenia, a diverse assortment of congenital malformations, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage), and defective DNA repair. WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/FA1ID102.html"; WEB RESOURCE: Name=Fanconi Anemia Mutation Database; URL="http://www.rockefeller.edu/fanconi/mutate/jumpa.html"; WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/FANCA"; WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/fanca/";
Caffeine Marilyn C Cornelis et al. PLoS genetics 2011, Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption., PLoS genetics.
[PubMed 21490707]
cervical intraepithelial neoplasia grade 3 Sophia S Wang , et al. The Journal of infectious diseases 2009 199(1):20-30, Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer., The Journal of infectious diseases 2009 199(1):20-30.
[PubMed 19012493]
Our results require replication but support the role of FANCA variants in cervical cancer susceptibility and of IRF3 in HPV persistence.
Hair Color Nicholas Eriksson et al. PLoS genetics 2010, Web-based, participant-driven studies yield novel genetic associations for common traits., PLoS genetics.
[PubMed 20585627]
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Pfam Domains: PF03511 - Fanconi anaemia group A protein PF15865 - Fanconi anaemia group A protein N terminus
ModBase Predicted Comparative 3D Structure on O15360
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0006281 DNA repair GO:0006974 cellular response to DNA damage stimulus GO:0007140 male meiosis GO:0008584 male gonad development GO:0008585 female gonad development GO:0036297 interstrand cross-link repair GO:0042127 regulation of cell proliferation GO:0045589 regulation of regulatory T cell differentiation GO:0050727 regulation of inflammatory response GO:0051090 regulation of sequence-specific DNA binding transcription factor activity GO:0065003 macromolecular complex assembly GO:2000348 regulation of CD40 signaling pathway
LF384492 - JP 2014500723-A/191995: Polycomb-Associated Non-Coding RNAs. CU689533 - Synthetic construct Homo sapiens gateway clone IMAGE:100019128 3' read ZNF276 mRNA. X99226 - H.sapiens mRNA for FAA protein. JD119421 - Sequence 100445 from Patent EP1572962. JD531228 - Sequence 512252 from Patent EP1572962. JD087793 - Sequence 68817 from Patent EP1572962. JD132968 - Sequence 113992 from Patent EP1572962. DQ574346 - Homo sapiens piRNA piR-42458, complete sequence. JD485787 - Sequence 466811 from Patent EP1572962. JD537774 - Sequence 518798 from Patent EP1572962. JD135184 - Sequence 116208 from Patent EP1572962. JD041141 - Sequence 22165 from Patent EP1572962. JD406166 - Sequence 387190 from Patent EP1572962. JD164541 - Sequence 145565 from Patent EP1572962. JD220172 - Sequence 201196 from Patent EP1572962. JD460098 - Sequence 441122 from Patent EP1572962. JD512961 - Sequence 493985 from Patent EP1572962. JD489600 - Sequence 470624 from Patent EP1572962. JD334538 - Sequence 315562 from Patent EP1572962. JD398181 - Sequence 379205 from Patent EP1572962. JD076810 - Sequence 57834 from Patent EP1572962. AK299282 - Homo sapiens cDNA FLJ61351 complete cds, highly similar to Fanconi anemia group A protein. JD391731 - Sequence 372755 from Patent EP1572962. JD134897 - Sequence 115921 from Patent EP1572962. JD538199 - Sequence 519223 from Patent EP1572962. BC156522 - Synthetic construct Homo sapiens clone IMAGE:100063088, MGC:190686 Fanconi anemia, complementation group A (FANCA) mRNA, encodes complete protein. BC172515 - Synthetic construct Homo sapiens clone IMAGE:100069209, MGC:199220 Fanconi anemia, complementation group A (FANCA) mRNA, encodes complete protein. AK301168 - Homo sapiens cDNA FLJ52775 complete cds, highly similar to Fanconi anemia group A protein. AY339880 - Homo sapiens nonfunctional Fanconi anemia complementation group A variant mRNA; alternatively spliced. AY339879 - Homo sapiens nonfunctional Fanconi anemia complementation group A variant mRNA; alternatively spliced. AY339878 - Homo sapiens nonfunctional Fanconi anemia complementation group A variant mRNA; alternatively spliced. BC022498 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:4800187), with apparent retained intron. BC008979 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:3456104), complete cds. BC064540 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:5725803), complete cds. BC120979 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:40115594), complete cds. BC127633 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:40115596), complete cds. BC120978 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:40115593), complete cds. BC141971 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:40115598), complete cds. BC141972 - Homo sapiens Fanconi anemia, complementation group A, mRNA (cDNA clone IMAGE:40115599), complete cds. BT007366 - Homo sapiens Fanconi anemia, complementation group A mRNA, complete cds. JD485193 - Sequence 466217 from Patent EP1572962. JD458559 - Sequence 439583 from Patent EP1572962. MA620069 - JP 2018138019-A/191995: Polycomb-Associated Non-Coding RNAs.
Biochemical and Signaling Pathways
BioCarta from NCI Cancer Genome Anatomy Project h_bard1Pathway - BRCA1-dependent Ub-ligase activity h_atrbrcaPathway - Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility
Reactome (by CSHL, EBI, and GO)
Protein O15360 (Reactome details) participates in the following event(s):
R-HSA-6785126 FA core complex assembles at DNA interstrand crosslinks (ICLs) R-HSA-6786155 POLN binds ICL-DNA R-HSA-6785342 FANCD2:FANCI complex and UBE2T bind ICL-DNA associated with the FA core complex R-HSA-6786171 FANCD2 deubiquitination by USP1:WDR48 R-HSA-6788385 The complex of ATR and ATRIP is recruited to ICL-DNA R-HSA-6785732 DNA nucleases bind monoubiquitinated ID2 complex R-HSA-6785361 Monoubiquitination of FANCD2:FANCI R-HSA-6788392 ATR phosphorylates RPA2, FANCI, FANCD2 and FANCM at ICL-DNA R-HSA-6783310 Fanconi Anemia Pathway R-HSA-73894 DNA Repair